Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) announced the results of its pharmacokinetic (PK) study for its dry powder inhaler product, APC-5000. The study was a Phase I PK study comparing the bioavailability of Adamis’ APC-5000 Dry Powder Inhaler (DPI) to GlaxoSmithKline’s Advair® Diskus® DPI. On Tuesday shares of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) closed at $6.82.
Pfizer Inc. (NYSE:PFE) announced that the European Commission approved an expanded indication for the use of Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) for the prevention of pneumonia caused by the 13 pneumococcal serotypes in the vaccine in adults aged 18 years and older. Pfizer Inc. (NYSE:PFE) in last trading activity decreased -0.60% to close at $34.56. Company weekly performance is 0.64% while its quarterly performance stands at 11.92%. Pfizer Inc. (NYSE:PFE) is -1.17% away from its 52 week high.
On last trading day PetMed Express, Inc. (NASDAQ:PETS) decreased -2.07% to close at $15.13. Its volatility for the week is 1.65% while volatility for the month is 2.07%. PETS’s sales growth for past 5 years was 1.20% and its EPS growth for past 5 years was -1.70%. PetMed Express, Inc. (NASDAQ:PETS) monthly performance is -3.63%.
On 24 February, Netlist, Inc. (NASDAQ:NLST) announced that it has closed its previously-announced underwritten public offering of 8,846,154 common shares at a price to the public of $1.30 per share. Netlist Inc. (NASDAQ:NLST) has 15.22% insider ownership while its institutional ownership stands at 11.20%. In last trading activity company’s stock closed at $1.28.
Colgate-Palmolive (NYSE: CL) declared a quarterly dividend of $0.38 per share, or $1.52 annualized. This is a 5.6% increase from the prior dividend of $0.36. The dividend will be payable on May 15, 2015, to stockholders of record on April 23, 2015, with an ex-dividend date of April 21, 2015. On last trading day Colgate-Palmolive Co. (NYSE:CL) fell -0.46% to close at $70.68. Its volatility for the week is 0.81% while volatility for the month is 1.10%. CL’s sales growth for past 5 years was 2.40% and its EPS growth for past 5 years was 1.60%. Colgate-Palmolive Co. (NYSE:CL) monthly performance is 4.68%.